Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
764 USD | -0.98% | +4.03% | +31.17% |
11:20am | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
May. 08 | China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.17% | 695B | |
+26.51% | 568B | |
-4.61% | 361B | |
+19.70% | 330B | |
+3.72% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+9.04% | 168B | |
+5.09% | 125B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly Calls for Regulatory Scrutiny of Novo Holding's Catalent Deal